loading

Design Therapeutics Inc Azioni (DSGN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
5.64%
21.57
20.42 16.69 16.25 15.04
Operating Income/Loss
5.64%
-21.57
-20.42 -16.69 -16.25 -15.04
Income/Loss From Continuing Operations Before Tax
7.72%
-19.08
-17.71 -13.65 -13.04 -11.79
Income/Loss From Continuing Operations After Tax
7.72%
-19.08
-17.71 -13.65 -13.04 -11.79
Net Income/Loss
7.72%
-19.08
-17.71 -13.65 -13.04 -11.79
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.18%
56.86
56.76 0.0318 56.62 56.56
Diluted Average Shares
0.18%
56.86
56.76 0.0318 56.62 56.56
Basic Earnings Per Share
9.68%
-0.34
-0.31 -0.24 -0.23 -0.21
Diluted Earnings Per Share
9.68%
-0.34
-0.31 -0.24 -0.23 -0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.32
price up icon 0.98%
$27.50
price up icon 0.31%
$25.74
price up icon 7.94%
$110.50
price up icon 7.16%
$144.73
price up icon 1.51%
biotechnology ONC
$339.41
price up icon 6.39%
Capitalizzazione:     |  Volume (24 ore):